Approve a perfume sample against a written brief and an identified sample version. Record what was evaluated, the agreed method, the observations and the exact scope of the decision. Liking a scent does not by itself complete safety, stability, packaging compatibility, label review or production-release checks.
Confirm the sample and the evaluation plan
Record the sample ID, formula or sample version supplied, packaging version and date received. Ask the technical team which evaluation method is appropriate for this sample and which supporting documents apply to its intended use and target market. Leave unavailable evidence marked pending rather than treating a document request as proof of compliance.
Do not apply a sample of unknown safety status directly to skin. Arrange any use evaluation with the responsible technical or safety reviewer. This buyer worksheet does not prescribe a skin test, a storage stress test or a universal pass/fail limit.
Record observations separately from conclusions
Use the agreed medium, amount and observation times, and record the conditions so that later versions can be compared. Describe the opening, later character and any unwanted impression in relation to the brief. If a reference sample is used, record its identity. Note appearance differences separately; do not infer their technical cause from appearance alone.
Ask the technical team to investigate unexpected changes and define any further checks. Informal observations do not establish safety, shelf life, regulatory compliance or packaging suitability. The evaluation period, revision rounds and test limits must be agreed for the project rather than presented as universal numbers.
Keep four approval decisions separate
| Review area | What to record | Decision boundary |
|---|---|---|
| Sensory preference | Brief, sample version, observations and requested changes | Preference approval for this version and stated use |
| Appearance deviation | Observed difference, agreed reference and technical follow-up | Do not diagnose the formula from a visual difference alone |
| Regulatory and label review | Target market, intended use, evidence and responsible reviewer | Keep pending until the responsible review is complete |
| Bulk-release review | Agreed production reference, acceptance basis and release responsibility | Sample preference approval is not batch release |
Copyable sample evaluation and approval record
Use one record for each sample version. Record observed results and the agreed evaluation basis. Sample preference approval does not complete safety, stability, packaging or bulk-release checks. Do not apply a sample of unknown safety status directly to skin.
Sample and evaluation context
- Project: ____________________
- Sample ID: ____________________
- Formula or sample version supplied: ____________________
- Packaging version supplied: ____________________
- Evaluator and role: ____________________
- Evaluation date: ____________________
- Agreed evaluation method and document reference: ____________________
- Test medium or application surface approved for this evaluation: ____________________
- Amount used and unit: ____________________
- Environment and relevant recorded conditions: ____________________
- Observation time points: ____________________
- Reference sample ID, if used: ____________________
Separate review decisions
Repeat this block for each review area: sensory preference, appearance deviation, regulatory/label review, and bulk-release review. Leave areas without a responsible reviewer or evidence pending. Do not use one signature to imply all areas are approved.
- Review area: ____________________
- Agreed criteria and source/version: ____________________
- Observed result or evidence reference: ____________________
- Status, such as pending, changes requested or approved for this area: ____________________
- Conditions, exclusions or unresolved checks: ____________________
- Responsible reviewer and role: ____________________
- Reviewer sign-off and date: ____________________
Version decision
- Exact sample and packaging version covered by this decision: ____________________
- Scope of approval, if any: ____________________
- Changes requested before the next review: ____________________
- Additional testing or review still required: ____________________
- Person responsible for the next action: ____________________
- Next review date, if agreed: ____________________
Close the review without losing the version trail
Send the record with the exact sample ID and version. State whether the decision is approval within a defined scope, changes requested, or pending evidence. Identify the next action and its owner. Keep the decision record, relevant correspondence and any retained sample arrangements agreed with the manufacturer together. Reconfirm the affected approval if the formula, packaging or intended use changes.
Use feedback for an iteration to describe the outcome you want; use the approval record to identify the version and scope you have accepted. Neither document should imply that unrelated checks are complete.
To discuss your project and its sampling requirements, contact Laeyo.